(Q34474961)

English

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

anti-retroviral agent

0 references

Simona Di Giambenedetto

10

object named as

Simona Di Giambenedetto

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Manuela Colafigli

object named as

Manuela Colafigli

5

0 references

Massimiliano Fabbiani

object named as

Massimiliano Fabbiani

2

0 references

object named as

Roberto Cauda

9

0 references

Alessandro D'Avino

7

object named as

Alessandro D'Avino

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

6

object named as

Annalisa Mondi

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Mattia A Prosperi

1

object named as

Mattia C F Prosperi

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

3

object named as

Iuri Fanti

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Zaccarelli Mauro

4

object named as

Mauro Zaccarelli

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Alberto Borghetti

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

12 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

296

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Analysis of neuropsychiatric adverse events during clinical trials of efavirenz in antiretroviral-naive patients: a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Predicting virologic failure in an HIV clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Short-term discontinuation of HAART regimens more common in vulnerable patient populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Gender differences in the treatment of HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

The challenge of HIV-1 subtype diversity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Antiretroviral pharmacokinetic profile: a review of sex differences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

6 July 2018

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Description of the first full-length HIV type 1 subtype F1 strain in Argentina: implications for the origin and dispersion of this subtype in South America

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

27 October 2018

Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519703

27 October 2018

Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-296

21 January 2018

Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23145925

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-12-296

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34474961&oldid=2196677028"